On September 12, 2023, Aaron Fletcher notified Cue Biopharma, Inc. (the ?Company?) of his decision to resign as a member of the Board of Directors of the Company (the ?Board?) and all committees thereof, effective on October 9, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.225 USD | +4.46% | +55.99% | -16.10% |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 | |
Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.10% | 104M | |
+8.86% | 105B | |
-0.57% | 104B | |
+5.79% | 22.94B | |
-12.75% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.92% | 16.96B | |
+8.15% | 14.16B | |
+39.21% | 12.63B |
- Stock Market
- Equities
- CUE Stock
- News Cue Biopharma, Inc.
- Cue Biopharma, Inc. Announces Resignation of Aaron Fletcher as Member of the Board of Directors, Effective October 9, 2023